The global prefilled syringes market size is expected to reach around US$ 15.56 billion by 2030 from US$ 6.49 billion in 2021 and is expected to grow at an impressive double-digit rate of 10.2% from 2022 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global prefilled syringes market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
The prefilled syringes make injections accurate, easy, and safe for, both, doctors and patient. Pre-filled syringes have is one of the fastest- growing selection for the medication of unit dose, as the pharmaceutical industry seeks new and more accessible medicine delivery styles.
In addition, pharmaceutical companies can get benefit by saving the cost of vials. Pharmaceutical key players are suitable to minimize medicine waste and increase product life span, while patients are suitable to self- administer injectable medicines at their home rather of the hospital. In addition, re-filled syringes have also stayed employed across a wide range of therapeutic sectors, similar as blood instigations, vaccines, and remedial proteins.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1575
Market Estimations Y-O-Y:
- Market Size Was Valued In 2021: US$ 6.49 Billion
- Market Size Is Projected to Grow By 2022: US$ 7.15 Billion
- Market Size Is Projected to Grow By 2023: US$ 7.85 Billion
- Market Size Is Projected to Grow By 2024: US$ 8.67 Billion
- Market Size Is Projected to Grow By 2025: US$ 9.55 Billion
- Market Size Is Projected to Grow By 2026: US$ 10.52 Billion
- Market Size Is Projected to Grow By 2027: US$ 11.60 Billion
- Market Size Is Projected to Grow By 2028: US$ 12.79 Billion
- Market Size Is Projected to Grow By 2029: US$ 14.11 Billion
- Market Size Is Projected to Grow By 2030: US$ 15.56 Billion
- Compound Annual Growth Rate (CAGR) from 2022 to 2030: 10.2 percent
Report Highlights
- On the basis of type, the segment named safety prefilled syringes is anticipated to foresee the highest growth rate during the forthcoming time period primarily due to the growing elderly population worldwide and presence of the rapies of biological for patients suffering from chronic diseases alleviates some of the pressure on hospitals.
- On the basis of material, the glass prefilled syringes segment accounted for the largest share of the prefilled syringes in 2020.
- On the basis of design, the single- chamber prefilled syringes segment accounted for the largest share of the prefilled syringes market.
- Europe is one of the major profit-generating regions in the market of prefilled syringes. Growing chronic diseases frequency, rise of the biosimilar and biologics market, geographical expansion by crucial manufacturers, growing population, technological advancements, and high adoption of self-injection equipment’s are boosting the demand for prefilled syringes which are self-injectable are the key factors boosting the growth of the prefilled syringes market in the European region.
Market Dynamics
Driver: Rising target complaint population
Prefilled syringes are substantially used for the treatment of chronic diseases, similar as diabetes, heart conditions, and autoimmune conditions, which bear patients to self-administer specifics. As a result, the adding prevalence and frequency of chronic and life conditions across the globe is a major factor contributing to the growth of the prefilled syringes market. Also, there’s a growing demand for self-injection equipments, considering the convenience and safety associated with their use.
Restraint: Dearth of prefilled syringes with intertwined safety features
Prefilled syringes give better safety of patient by diminishing the potential for unintended needle sticks and poisonous products exposure that can do while drawing drug from vials. In similar patients, the defiled needle of prefilled syringes can lead to blood- borne infections, similar as HIV and HCV. In addition, the partial prefilled syringes market presence with intertwined safety features, due to their challenging and expensive manufacturing procedure, is a major concern in the market. Still, this trend is anticipated to change in the coming times, as the healthcare market is laying lesser emphasis on reducing the rate of needle stick injuries, which, in turn, is paving the way for the development of safety prefilled hypes.
Opportunity: Growing healthcare structure across arising markets
Emerging economies will continue to suffer from inadequate healthcare backing, which negatively affects access to quality, healthcare, and, eventually, the health status of citizens. According to the World Bank, roughly 400 million people lacks access to essential healthcare services, substantially in Africa and South Asia. Likewise, accelerating medical affectation, the cost of medical treatments and an advanced frequency of non-communicable life- related conditions similar as diabetes, cancer, or cardiac arrest, have rebounded in funding gaps.
According Geneva Association report, in the last 20 years, the share of the aggregate global healthcare expenditure in GDP has raised from about 8% to nearly 10%, or an estimated US$8000 billion per year, which is boosted by the expanding treatment options, medical treatment accelerating cost and adding client demands. Also, the Global Burden of Disease Health Financing Collaborator Network (2017) estimates that global spending on health will nearly triple to USD 24 trillion by 2040 with upper-middle- income countries are estimated to show the fastest increase at a normal of5.3% per time. This growth could be attributed to uninterrupted growth in GDP and the rise of the middle class and government spending.
Related Reports
Challenge: Availability of cheaper alternatives
Traditionally, injectable were painful and invasive in nature, which was the major concern for patients to prefer medicine delivery alternate routes, such as topical, oral, and nasal. In addition, among the various routes of medicine delivery, the oral route is the most preferred as it’s easy to use, accessible, cost-effective, safe, and respectable. Due to the above mentioned factors, the adoption of indispensable medicine delivery technologies is adding across the globe. Like, cost-effective delivery styles development for insulin, alternate, similar as Medtronic’s Veo insulin and Pfizer’s Exubera pump, is restraining the usage of injectable insulin. Presently, insulin is substantially administered via injections, and therefore, injections of insulin form a significant market for injectable medicine delivery technologies. Still, the arrival of inhalable insulin is anticipated to significantly impact the growth of this market as nasal medicine delivery is pain-free and largely patient biddable.
Why should you invest in this report?
If you are aiming to enter the global prefilled syringes market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for prefilled syringes are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global prefilled syringes market include:
- SCHOTT AG
- West Pharmaceutical Services, Inc.
- Baxter International Inc.
- Weigao Group
- Vetter Pharma International GmbH
- Nipro Corporation
- Elcam Medical
- Oval Medical Technologies
- SHL Medical AG
- Terumo
Segments Covered in the Report
By Type
- Conventional Prefilled Syringes
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
- Safety Prefilled Syringes
By Material
- Glass
- Plastic
By Design
- Single-Chamber
- Dual- Chamber
- Customized
By Product
- Complete Syringe Set
- Components and Accessories
By Application
- Diabetes
- Rheumatoid Arthritis
- Anaphylaxis
- Cancer
- Thrombosis
- Ophthalmology
- Others
By Closing System
- Staked Needle System
- Luer Cone System
- Luer Lock Form System
By End User
- Pharmaceutical and Biotechnology Companies
- Contract Research and Manufacturing Organizations
- Others
Regional Analysis:
The geographical analysis of the global prefilled syringes market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global prefilled syringes Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global prefilled syringes market in 2030?
- What is the expected CAGR for the prefilled syringes market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global prefilled syringes market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Prefilled Syringes Market, By Type
7.1. Prefilled Syringes Market, by Type, 2022-2030
7.1.1. Conventional Prefilled Syringes
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Safety Prefilled Syringes
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Prefilled Syringes Market, By Design
8.1. Prefilled Syringes Market, by Design, 2022-2030
8.1.1. Single-Chamber
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Dual- Chamber
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Customized
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Prefilled Syringes Market, By Application
9.1. Prefilled Syringes Market, by Application, 2022-2030
9.1.1. Diabetes
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Rheumatoid Arthritis
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Anaphylaxis
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Cancer
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Thrombosis
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Ophthalmology
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Prefilled Syringes Market, By Product
10.1. Prefilled Syringes Market, by Product, 2022-2030
10.1.1. Complete Syringe Set
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Components and Accessories
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Prefilled Syringes Market, By End-use
11.1. Prefilled Syringes Market, by End-use, 2022-2030
11.1.1. Pharmaceutical and Biotechnology Companies
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Contract Research and Manufacturing Organizations
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Prefilled Syringes Market, By Closing System
12.1. Prefilled Syringes Market, by Closing System, 2022-2030
12.1.1. Staked Needle System
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Luer Cone System
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Luer Lock Form System
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Prefilled Syringes Market, By Material
13.1. Prefilled Syringes Market, by Material, 2022-2030
13.1.1. Glass
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Plastics
13.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Prefilled Syringes Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.2. Market Revenue and Forecast, by Design (2017-2030)
14.1.3. Market Revenue and Forecast, by Application (2017-2030)
14.1.4. Market Revenue and Forecast, by Product (2017-2030)
14.1.5. Market Revenue and Forecast, by End-use (2017-2030)
14.1.6. Market Revenue and Forecast, by Material (2017-2030)
14.1.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.8.2. Market Revenue and Forecast, by Design (2017-2030)
14.1.8.3. Market Revenue and Forecast, by Application (2017-2030)
14.1.8.4. Market Revenue and Forecast, by Product (2017-2030)
14.1.8.5. Market Revenue and Forecast, by End-use (2017-2030)
14.1.8.6. Market Revenue and Forecast, by Material (2017-2030)
14.1.8.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Design (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Application (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.5. Market Revenue and Forecast, by End-use (2017-2030)
14.1.9.6. Market Revenue and Forecast, by Material (2017-2030)
14.1.9.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.2. Market Revenue and Forecast, by Design (2017-2030)
14.2.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.4. Market Revenue and Forecast, by Product (2017-2030)
14.2.5. Market Revenue and Forecast, by End-use (2017-2030)
14.2.6. Market Revenue and Forecast, by Material (2017-2030)
14.2.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Design (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.8.4. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.5. Market Revenue and Forecast, by End-use (2017-2030)
14.2.8.6. Market Revenue and Forecast, by Material (2017-2030)
14.2.8.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.9.2. Market Revenue and Forecast, by Design (2017-2030)
14.2.9.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.9.4. Market Revenue and Forecast, by Product (2017-2030)
14.2.9.5. Market Revenue and Forecast, by End-use (2017-2030)
14.2.9.6. Market Revenue and Forecast, by Material (2017-2030)
14.2.9.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.10.2. Market Revenue and Forecast, by Design (2017-2030)
14.2.10.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.10.4. Market Revenue and Forecast, by Product (2017-2030)
14.2.10.5. Market Revenue and Forecast, by End-use (2017-2030)
14.2.10.6. Market Revenue and Forecast, by Material (2017-2030)
14.2.10.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Design (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.11.4. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.5. Market Revenue and Forecast, by End-use (2017-2030)
14.2.11.6. Market Revenue and Forecast, by Material (2017-2030)
14.2.11.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.2. Market Revenue and Forecast, by Design (2017-2030)
14.3.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.4. Market Revenue and Forecast, by Product (2017-2030)
14.3.5. Market Revenue and Forecast, by End-use (2017-2030)
14.3.6. Market Revenue and Forecast, by Material (2017-2030)
14.3.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.8.2. Market Revenue and Forecast, by Design (2017-2030)
14.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.8.4. Market Revenue and Forecast, by Product (2017-2030)
14.3.8.5. Market Revenue and Forecast, by End-use (2017-2030)
14.3.8.6. Market Revenue and Forecast, by Material (2017-2030)
14.3.8.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.9.2. Market Revenue and Forecast, by Design (2017-2030)
14.3.9.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.9.4. Market Revenue and Forecast, by Product (2017-2030)
14.3.9.5. Market Revenue and Forecast, by End-use (2017-2030)
14.3.9.6. Market Revenue and Forecast, by Material (2017-2030)
14.3.9.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Design (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.5. Market Revenue and Forecast, by End-use (2017-2030)
14.3.10.6. Market Revenue and Forecast, by Material (2017-2030)
14.3.10.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.11.2. Market Revenue and Forecast, by Design (2017-2030)
14.3.11.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.11.4. Market Revenue and Forecast, by Product (2017-2030)
14.3.11.5. Market Revenue and Forecast, by End-use (2017-2030)
14.3.11.6. Market Revenue and Forecast, by Material (2017-2030)
14.3.11.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.2. Market Revenue and Forecast, by Design (2017-2030)
14.4.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.4. Market Revenue and Forecast, by Product (2017-2030)
14.4.5. Market Revenue and Forecast, by End-use (2017-2030)
14.4.6. Market Revenue and Forecast, by Material (2017-2030)
14.4.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.8.2. Market Revenue and Forecast, by Design (2017-2030)
14.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.8.4. Market Revenue and Forecast, by Product (2017-2030)
14.4.8.5. Market Revenue and Forecast, by End-use (2017-2030)
14.4.8.6. Market Revenue and Forecast, by Material (2017-2030)
14.4.8.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.9.2. Market Revenue and Forecast, by Design (2017-2030)
14.4.9.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.9.4. Market Revenue and Forecast, by Product (2017-2030)
14.4.9.5. Market Revenue and Forecast, by End-use (2017-2030)
14.4.9.6. Market Revenue and Forecast, by Material (2017-2030)
14.4.9.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Design (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.5. Market Revenue and Forecast, by End-use (2017-2030)
14.4.10.6. Market Revenue and Forecast, by Material (2017-2030)
14.4.10.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.11.2. Market Revenue and Forecast, by Design (2017-2030)
14.4.11.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.11.4. Market Revenue and Forecast, by Product (2017-2030)
14.4.11.5. Market Revenue and Forecast, by End-use (2017-2030)
14.4.11.6. Market Revenue and Forecast, by Material (2017-2030)
14.4.11.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.2. Market Revenue and Forecast, by Design (2017-2030)
14.5.3. Market Revenue and Forecast, by Application (2017-2030)
14.5.4. Market Revenue and Forecast, by Product (2017-2030)
14.5.5. Market Revenue and Forecast, by End-use (2017-2030)
14.5.6. Market Revenue and Forecast, by Material (2017-2030)
14.5.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.8.2. Market Revenue and Forecast, by Design (2017-2030)
14.5.8.3. Market Revenue and Forecast, by Application (2017-2030)
14.5.8.4. Market Revenue and Forecast, by Product (2017-2030)
14.5.8.5. Market Revenue and Forecast, by End-use (2017-2030)
14.5.8.6. Market Revenue and Forecast, by Material (2017-2030)
14.5.8.7. Market Revenue and Forecast, by Closing System (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Design (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Application (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.5. Market Revenue and Forecast, by End-use (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Material (2017-2030)
14.5.9.7. Market Revenue and Forecast, by Closing System (2017-2030)
Chapter 15. Company Profiles
15.1. SCHOTT AG
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. West Pharmaceutical Services, Inc.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Baxter International Inc.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Weigao Group
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Vetter Pharma International GmbH
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Nipro Corporation
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Elcam Medical
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Oval Medical Technologies
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. SHL Medical AG
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Terumo
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1575
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments